エノキサパリンAPIの市場調査レポート 2025年

このレポートは、定量的および定性的な分析の両方を用いて、エノキサパリン API の世界市場を包括的に紹介し、読者がビジネス/成長戦略を策定し、市場の競争状況を評価し、現在の市場でのポジションを分析し、エノキサパリン API に関する情報に基づいたビジネス上の意思決定を行うのに役立つことを目的としています。

Global Enoxaparin API market size in terms of revenue is projected to reach 287.08 million USD by 2031 from 171.30 million USD in 2024, with a CAGR 5.38% during 2025-2031.

世界のエノキサパリン API 市場規模は、2025年から2031年にかけて5.38%のCAGRで成長し、2024年の1億7,130万米ドルから2031年には2億8,708万米ドルに達すると予測されています。

North America market for Enoxaparin API is estimated to increase from 28.17 million USD in 2024 to reach 40.23 million USD by 2031, at a CAGR of 3.86% during the forecast period of 2025 through 2031.

Europe market for Enoxaparin API is estimated to increase from 94.34 million USD in 2024 to reach 153.91 million USD by 2031, at a CAGR of 4.68% during the forecast period of 2025 through 2031.

Asia-Pacific market for Enoxaparin API is estimated to increase from 40.34 million USD in 2024 to reach 77.75 million USD by 2031, at a CAGR of 7.46% during the forecast period of 2025 through 2031.

The major global manufacturers of Enoxaparin API include Hepalink, Yantai Dongcheng Pharmaceutical, Changzhou Qianhong Biopharma, Hebei Changshan Biochemical Pharmaceutical, Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical), Chongqing Yino Pharma, Chengdu Baiyu Pharmaceutical, Haike Group, Jiangxi Haoran Bio-Pharma, Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical), etc. In 2024, the world’s top five vendors accounted for approximately 69.88% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enoxaparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin API.

The Enoxaparin API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enoxaparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enoxaparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

•                 Hepalink
•                 Yantai Dongcheng Pharmaceutical
•                 Changzhou Qianhong Biopharma
•                 Hebei Changshan Biochemical Pharmaceutical
•                 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical)
•                 Chongqing Yino Pharma
•                 Chengdu Baiyu Pharmaceutical
•                 Haike Group
•                 Jiangxi Haoran Bio-Pharma
•                 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical)
•                 Stanex

Segment by Anti-factor Xa Activity

•                 Above 100 IU/mg
•                 Below 100 IU/mg

Segment by Application

•                 0.2ml:2000IU
•                 0.4ml:4000IU
•                 0.6ml:6000IU
•                 0.8ml:8000IU
•                 1ml:10000IU
•                 Others

Production by Region

•                 North America
•                 Europe
•                 China
•                 India

Consumption by Region

North America

•                 U.S.
•                 Canada

Asia-Pacific

•                 China
•                 Japan
•                 South Korea
•                 Southeast Asia
•                 India
•                 Australia

Europe

•                 Germany
•                 France
•                 U.K.
•                 Italy
•                 Spain
•                 Rest of Europe

Latin America

•                 Mexico
•                 Brazil

Middle East & Africa

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Enoxaparin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3:  Production/output, value of Enoxaparin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4:  Consumption of Enoxaparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Enoxaparin API Market Overview 1

1.1 Product Definition         1

1.2 Enoxaparin API by Anti-factor Xa Activity                1

1.2.1 Global Enoxaparin API Market Value Growth Rate Analysis by Anti-factor Xa Activity: 2024 VS 2031       2

1.2.2 Above 100 IU/mg       3

1.2.3 Below 100 IU/mg       3

1.3 Enoxaparin API by Application   3

1.3.1 Global Enoxaparin API Market Value Growth Rate Analysis by Application: 2024 VS 2031 4

1.3.2 0.2ml:2000IU               6

1.3.3 0.4ml:4000IU               6

1.3.4 0.6ml:6000IU               6

1.3.5 0.8ml:8000IU               6

1.3.6 1ml:10000IU                6

1.3.7 Others           6

1.4 Global Market Growth Prospects                7

1.4.1 Global Enoxaparin API Production Value Estimates and Forecasts (2020-2031)           7

1.4.2 Global Enoxaparin API Production Capacity Estimates and Forecasts (2020-2031)           8

1.4.3 Global Enoxaparin API Production Estimates and Forecasts (2020-2031)      9

1.4.4 Global Enoxaparin API Market Average Price Estimates and Forecasts (2020-2031)         10

1.5 Assumptions and Limitations       10

2 Market Competition by Manufacturers         13

2.1 Global Enoxaparin API Production Market Share by Manufacturers (2020-2025)           13

2.2 Global Enoxaparin API Production Value Market Share by Manufacturers (2020-2025)                15

2.3 Global Key Players of Enoxaparin API, Industry Ranking, 2023 VS 2024        16

2.4 Global Enoxaparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)       17

2.5 Global Enoxaparin API Average Price by Manufacturers (2020-2025)                 18

2.6 Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters         19

2.7 Global Key Manufacturers of Enoxaparin API, Product Type & Application            20

2.8 Global Key Manufacturers of Enoxaparin API, Date of Enter into This Industry 20

2.9 Global Enoxaparin API Market Competitive Situation and Trends                 21

2.9.1 Global Enoxaparin API Market Concentration Rate             21

2.9.2 Global 5 and 10 Largest Enoxaparin API Players Market Share by Revenue 22

2.10 Mergers & Acquisitions, Expansion          23

3 Enoxaparin API Production by Region          24

3.1 Global Enoxaparin API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031          24

3.2 Global Enoxaparin API Production Value by Region (2020-2031)                 26

3.2.1 Global Enoxaparin API Production Value Market Share by Region (2020-2025)           26

3.2.2 Global Forecasted Production Value of Enoxaparin API by Region (2026-2031)           26

3.3 Global Enoxaparin API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031        27

3.4 Global Enoxaparin API Production by Region (2020-2031)   29

3.4.1 Global Enoxaparin API Production Market Share by Region (2020-2025)      29

3.4.2 Global Forecasted Production of Enoxaparin API by Region (2026-2031)      29

3.5 Global Enoxaparin API Market Price Analysis by Region (2020-2025)                 30

3.6 Global Enoxaparin API Production and Value, Year-over-Year Growth                 31

3.6.1 North America Enoxaparin API Production Value Estimates and Forecasts (2020-2031)         31

3.6.2 Europe Enoxaparin API Production Value Estimates and Forecasts (2020-2031)           31

3.6.3 China Enoxaparin API Production Value Estimates and Forecasts (2020-2031)           32

3.6.4 India Enoxaparin API Production Value Estimates and Forecasts (2020-2031)           33

4 Enoxaparin API Consumption by Region      34

4.1 Global Enoxaparin API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031          34

4.2 Global Enoxaparin API Consumption by Region (2020-2031)                 36

4.2.1 Global Enoxaparin API Consumption by Region (2020-2031)                 36

4.2.2 Global Enoxaparin API Forecasted Consumption by Region (2026-2031)      36

4.3 North America                37

4.3.1 North America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031       38

4.3.2 North America Enoxaparin API Consumption by Country (2020-2031)      38

4.3.3 U.S.               39

4.3.4 Canada          40

4.4 Europe             40

4.4.1 Europe Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031        41

4.4.2 Europe Enoxaparin API Consumption by Country (2020-2031)                 41

4.4.3 Germany      43

4.4.4 France           43

4.4.5 U.K.               44

4.4.6 Italy               44

4.4.7 Spain             45

4.5 Asia Pacific     45

4.5.1 Asia Pacific Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031        46

4.5.2 Asia Pacific Enoxaparin API Consumption by Region (2020-2031)                 46

4.5.3 China            48

4.5.4 Japan             48

4.5.5 South Korea 49

4.5.6 Southeast Asia             49

4.5.7 India              50

4.5.8 Australia       50

4.6 Latin America 51

4.6.1 Latin America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031       51

4.6.2 Latin America Enoxaparin API Consumption by Country (2020-2031)      52

4.6.3 Mexico          53

4.6.4 Brazil            53

4.7 Middle East and Africa 54

5 Segment by Anti-factor Xa Activity                55

5.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2031)      55

5.1.1 Global Enoxaparin API Production by Anti-factor Xa Activity (2020-2025)      55

5.1.2 Global Enoxaparin API Production by Anti-factor Xa Activity (2026-2031)      55

5.1.3 Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2020-2031)            55

5.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2031)           57

5.2.1 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2020-2025)           57

5.2.2 Global Enoxaparin API Production Value by Anti-factor Xa Activity (2026-2031)           57

5.2.3 Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2020-2031)           57

5.3 Global Enoxaparin API Price by Anti-factor Xa Activity (2020-2031)                 59

6 Segment by Application   60

6.1 Global Enoxaparin API Production by Application (2020-2031)                 60

6.1.1 Global Enoxaparin API Production by Application (2020-2025)                 60

6.1.2 Global Enoxaparin API Production by Application (2026-2031)                 60

6.1.3 Global Enoxaparin API Production Market Share by Application (2020-2031)           61

6.2 Global Enoxaparin API Production Value by Application (2020-2031)                 62

6.2.1 Global Enoxaparin API Production Value by Application (2020-2025)      62

6.2.2 Global Enoxaparin API Production Value by Application (2026-2031)      63

6.2.3 Global Enoxaparin API Production Value Market Share by Application (2020-2031)     63

6.3 Global Enoxaparin API Price by Application (2020-2031)     64

7 Key Companies Profiled  66

7.1 Hepalink          66

7.1.1 Hepalink Enoxaparin API Company Information 66

7.1.2 Hepalink Enoxaparin API Product Portfolio          67

7.1.3 Hepalink Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)             67

7.1.4 Hepalink Main Business and Markets Served        68

7.1.5 Hepalink Recent Developments/Updates               68

7.2 Yantai Dongcheng Pharmaceutical             68

7.2.1 Yantai Dongcheng Pharmaceutical Enoxaparin API Company Information            68

7.2.2 Yantai Dongcheng Pharmaceutical Enoxaparin API Product Portfolio 69

7.2.3 Yantai Dongcheng Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)   70

7.2.4 Yantai Dongcheng Pharmaceutical Main Business and Markets Served    70

7.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates                 70

7.3 Changzhou Qianhong Biopharma               71

7.3.1 Changzhou Qianhong Biopharma Enoxaparin API Company Information            71

7.3.2 Changzhou Qianhong Biopharma Enoxaparin API Product Portfolio                 71

7.3.3 Changzhou Qianhong Biopharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)                72

7.3.4 Changzhou Qianhong Biopharma Main Business and Markets Served    72

7.3.5 Changzhou Qianhong Biopharma Recent Developments/Updates                 73

7.4 Hebei Changshan Biochemical Pharmaceutical        73

7.4.1 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Company Information          73

7.4.2 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Product Portfolio  74

7.4.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)              75

7.4.4 Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served     76

7.4.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates      76

7.5 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical)                 76

7.5.1 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Company Information               77

7.5.2 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Product Portfolio       77

7.5.3 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)             78

7.5.4 Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Main Business and Markets Served     78

7.6 Chongqing Yino Pharma               79

7.6.1 Chongqing Yino Pharma Enoxaparin API Company Information                 79

7.6.2 Chongqing Yino Pharma Enoxaparin API Product Portfolio                 79

7.6.3 Chongqing Yino Pharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)          80

7.6.4 Chongqing Yino Pharma Main Business and Markets Served                 80

7.7 Chengdu Baiyu Pharmaceutical  80

7.7.1 Chengdu Baiyu Pharmaceutical Enoxaparin API Company Information            80

7.7.2 Chengdu Baiyu Pharmaceutical Enoxaparin API Product Portfolio                 81

7.7.3 Chengdu Baiyu Pharmaceutical Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)                81

7.7.4 Chengdu Baiyu Pharmaceutical Main Business and Markets Served                 81

7.7.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates                 82

7.8 Haike Group   82

7.8.1 Haike Group Enoxaparin API Company Information           82

7.8.2 Haike Group Enoxaparin API Product Portfolio   83

7.8.3 Haike Group Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)             83

7.8.4 Haike Group Main Business and Markets Served 84

7.9 Jiangxi Haoran Bio-Pharma         84

7.9.1 Jiangxi Haoran Bio-Pharma Enoxaparin API Company Information                 84

7.9.2 Jiangxi Haoran Bio-Pharma Enoxaparin API Product Portfolio                 85

7.9.3 Jiangxi Haoran Bio-Pharma Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)                86

7.9.4 Jiangxi Haoran Bio-Pharma Main Business and Markets Served                 86

7.10 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical)                 86

7.10.1 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Company Information             87

7.10.2 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Product Portfolio     87

7.10.3 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)                 88

7.10.4 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Main Business and Markets Served              88

7.10.5 Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Recent Developments/Updates         89

7.11 Stanex            89

7.11.1 Stanex Enoxaparin API Company Information    90

7.11.2 Stanex Enoxaparin API Product Portfolio            90

7.11.3 Stanex Enoxaparin API Production, Value, Price and Gross Margin (2020-2025)           90

7.11.4 Stanex Main Business and Markets Served          91

8 Industry Chain and Sales Channels Analysis                 92

8.1 Enoxaparin API Industry Chain Analysis  92

8.2 Enoxaparin API Raw Material Supply Analysis         92

8.2.1 Key Raw Materials      93

8.2.2 Raw Materials Key Suppliers    93

8.3 Enoxaparin API Production Mode & Process Analysis            94

8.4 Enoxaparin API Sales and Marketing         96

8.4.1 Enoxaparin API Sales Channels                96

8.4.2 Enoxaparin API Distributors    97

8.5 Enoxaparin API Customer Analysis            97

9 Enoxaparin API Market Dynamics 99

9.1 Enoxaparin API Industry Trends                 99

9.2 Enoxaparin API Market Drivers  100

9.3 Enoxaparin API Market Challenges            101

9.4 Enoxaparin API Market Restraints              102

10 Research Findings and Conclusion               103

11 Methodology and Data Source     105

11.1 Methodology/Research Approach             105

11.1.1 Research Programs/Design    105

11.1.2 Market Size Estimation            106

11.1.3 Market Breakdown and Data Triangulation         107

11.2 Data Source  108

11.2.1 Secondary Sources   108

11.2.2 Primary Sources        109

11.3 Author List   110

11.4 Disclaimer    111

Tables and Figures

Table 1. Global Enoxaparin API Market Value by Anti-factor Xa Activity, (US$ Million) & (2024 VS 2031)       2

Table 2. Global Enoxaparin API Market Value by Application, (US$ Million) & (2024 VS 2031)       4

Table 3. Global Enoxaparin API Production by Manufacturers (2020-2025) & (Kg)         13

Table 4. Global Enoxaparin API Production Market Share by Manufacturers (2020-2025)                14

Table 5. Global Enoxaparin API Production Value by Manufacturers (2020-2025) & (US$ Million)            15

Table 6. Global Enoxaparin API Production Value Share by Manufacturers (2020-2025)           15

Table 7. Global Key Players of Enoxaparin API, Industry Ranking, 2024 VS 2025  16

Table 8. Global Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Enoxaparin API as of 2024)     17

Table 9. Global Market Enoxaparin API Average Price by Manufacturers (USD/Kg) & (2020-2025)  18

Table 10. Global Key Manufacturers of Enoxaparin API, Manufacturing Sites & Headquarters           19

Table 11. Global Key Manufacturers of Enoxaparin API, Product Type & Application            20

Table 12. Global Key Manufacturers of Enoxaparin API, Date of Enter into This Industry         20

Table 13. Global Enoxaparin API Manufacturers Market Concentration Ratio (CR5 and HHI)          21

Table 14. Mergers & Acquisitions, Expansion Plans      23

Table 15. Global Enoxaparin API Production Value Growth Rate by Region: 2020 VS 2024 VS 2031 (US$ Million)                24

Table 16. Global Enoxaparin API Production Value (US$ Million) by Region (2020-2025)             26

Table 17. Global Enoxaparin API Production Value Market Share by Region (2020-2025)             26

Table 18. Global Enoxaparin API Production Value (US$ Million) Forecast by Region (2026-2031)        26

Table 19. Global Enoxaparin API Production Value Market Share Forecast by Region (2026-2031)        27

Table 20. Global Enoxaparin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)        27

Table 21. Global Enoxaparin API Production (Kg) by Region (2020-2025)                 29

Table 22. Global Enoxaparin API Production Market Share by Region (2020-2025)           29

Table 23. Global Enoxaparin API Production (Kg) Forecast by Region (2026-2031)           29

Table 24. Global Enoxaparin API Production Market Share Forecast by Region (2026-2031)             30

Table 25. Global Enoxaparin API Market Average Price (USD/Kg) by Region (2020-2025)             30

Table 26. Global Enoxaparin API Market Average Price (USD/Kg) by Region (2026-2031)             30

Table 27. Global Enoxaparin API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)               34

Table 28. Global Enoxaparin API Consumption by Region (2020-2025) & (Kg)        36

Table 29. Global Enoxaparin API Consumption Market Share by Region (2020-2025)           36

Table 30. Global Enoxaparin API Forecasted Consumption by Region (2026-2031) & (Kg)             36

Table 31. Global Enoxaparin API Forecasted Consumption Market Share by Region (2020-2025)        37

Table 32. North America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)              38

Table 33. North America Enoxaparin API Consumption by Country (2020-2025) & (Kg)             38

Table 34. North America Enoxaparin API Consumption by Country (2026-2031) & (Kg)             38

Table 35. Europe Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)               41

Table 36. Europe Enoxaparin API Consumption by Country (2020-2025) & (Kg)    41

Table 37. Europe Enoxaparin API Consumption by Country (2026-2031) & (Kg)    41

Table 38. Asia Pacific Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)              46

Table 39. Asia Pacific Enoxaparin API Consumption by Region (2020-2025) & (Kg)         46

Table 40. Asia Pacific Enoxaparin API Consumption by Region (2026-2031) & (Kg)         47

Table 41. Latin America Enoxaparin API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)              51

Table 42. Latin America Enoxaparin API Consumption by Country (2020-2025) & (Kg)         52

Table 43. Latin America Enoxaparin API Consumption by Country (2026-2031) & (Kg)         52

Table 44. Global Enoxaparin API Production (Kg) by Anti-factor Xa Activity (2020-2025)            55

Table 45. Global Enoxaparin API Production (Kg) by Anti-factor Xa Activity (2026-2031)            55

Table 46. Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2020-2025)      55

Table 47. Global Enoxaparin API Production Market Share by Anti-factor Xa Activity (2026-2031)      56

Table 48. Global Enoxaparin API Production Value (US$ Million) by Anti-factor Xa Activity (2020-2025)           57

Table 49. Global Enoxaparin API Production Value (US$ Million) by Anti-factor Xa Activity (2026-2031)           57

Table 50. Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2020-2025)           57

Table 51. Global Enoxaparin API Production Value Market Share by Anti-factor Xa Activity (2026-2031)           58

Table 52. Global Enoxaparin API Price (USD/Kg) by Anti-factor Xa Activity (2020-2025)            59

Table 53. Global Enoxaparin API Price (USD/Kg) by Anti-factor Xa Activity (2026-2031)            59

Table 54. Global Enoxaparin API Production (Kg) by Application (2020-2025)      60

Table 55. Global Enoxaparin API Production (Kg) by Application (2026-2031)      60

Table 56. Global Enoxaparin API Production Market Share by Application (2020-2025)           61

Table 57. Global Enoxaparin API Production Market Share by Application (2026-2031)           61

Table 58. Global Enoxaparin API Production Value (US$ Million) by Application (2020-2025)     62

Table 59. Global Enoxaparin API Production Value (US$ Million) by Application (2026-2031)     63

Table 60. Global Enoxaparin API Production Value Market Share by Application (2020-2025)     63

Table 61. Global Enoxaparin API Production Value Market Share by Application (2026-2031)     63

Table 62. Global Enoxaparin API Price (USD/Kg) by Application (2020-2025)      64

Table 63. Global Enoxaparin API Price (USD/Kg) by Application (2026-2031)      65

Table 64. Hepalink Enoxaparin API Company Information          66

Table 65. Hepalink Enoxaparin API Specification and Application                 67

Table 66. Hepalink Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)            67

Table 67. Hepalink Main Business and Markets Served                 68

Table 68. Hepalink Recent Developments/Updates      68

Table 69. Yantai Dongcheng Pharmaceutical Enoxaparin API Company Information            68

Table 70. Yantai Dongcheng Pharmaceutical Enoxaparin API Specification and Application             69

Table 71. Yantai Dongcheng Pharmaceutical Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)      70

Table 72. Yantai Dongcheng Pharmaceutical Main Business and Markets Served    70

Table 73. Yantai Dongcheng Pharmaceutical Recent Developments/Updates      70

Table 74. Changzhou Qianhong Biopharma Enoxaparin API Company Information            71

Table 75. Changzhou Qianhong Biopharma Enoxaparin API Specification and Application    71

Table 76. Changzhou Qianhong Biopharma Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)      72

Table 77. Changzhou Qianhong Biopharma Main Business and Markets Served    72

Table 78. Changzhou Qianhong Biopharma Recent Developments/Updates      73

Table 79. Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Company Information          73

Table 80. Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Specification and Application             74

Table 81. Hebei Changshan Biochemical Pharmaceutical Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)           75

Table 82. Hebei Changshan Biochemical Pharmaceutical Main Business and Markets Served              76

Table 83. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates      76

Table 84. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Company Information               77

Table 85. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Specification and Application 77

Table 86. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)            78

Table 87. Hubei Enoray Biopharmaceutical (Tianjin Chasesun Pharmaceutical) Main Business and Markets Served     78

Table 88. Chongqing Yino Pharma Enoxaparin API Company Information                 79

Table 89. Chongqing Yino Pharma Enoxaparin API Specification and Application            79

Table 90. Chongqing Yino Pharma Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)                 80

Table 91. Chongqing Yino Pharma Main Business and Markets Served                 80

Table 92. Chengdu Baiyu Pharmaceutical Enoxaparin API Company Information            80

Table 93. Chengdu Baiyu Pharmaceutical Enoxaparin API Specification and Application    81

Table 94. Chengdu Baiyu Pharmaceutical Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)      81

Table 95. Chengdu Baiyu Pharmaceutical Main Business and Markets Served    81

Table 96. Chengdu Baiyu Pharmaceutical Recent Developments/Updates                 82

Table 97. Haike Group Enoxaparin API Company Information   82

Table 98. Haike Group Enoxaparin API Specification and Application                 83

Table 99. Haike Group Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)                 83

Table 100. Haike Group Main Business and Markets Served       84

Table 101. Jiangxi Haoran Bio-Pharma Enoxaparin API Company Information            84

Table 102. Jiangxi Haoran Bio-Pharma Enoxaparin API Specification and Application            85

Table 103. Jiangxi Haoran Bio-Pharma Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)                 86

Table 104. Jiangxi Haoran Bio-Pharma Main Business and Markets Served                 86

Table 105. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Company Information             87

Table 106. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Specification and Application                87

Table 107. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)          88

Table 108. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Main Business and Markets Served   88

Table 109. Shandong Chenlong Pharmaceutical (Cisen Pharmaceutical) Recent Developments/Updates         89

Table 110. Stanex Enoxaparin API Company Information            90

Table 111. Stanex Enoxaparin API Specification and Application                 90

Table 112. Stanex Enoxaparin API Production (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)            90

Table 113. Stanex Main Business and Markets Served  91

Table 114. Key Raw Materials Lists  93

Table 115. Raw Materials Key Suppliers Lists 93

Table 116. Enoxaparin API Distributors List  97

Table 117. Enoxaparin API Customers List     97

Table 118. Enoxaparin API Market Trends     99

Table 119. Enoxaparin API Market Drivers    100

Table 120. Enoxaparin API Market Challenges               101

Table 121. Enoxaparin API Market Restraints                 102

Table 122. Research Programs/Design for This Report                 105

Table 123. Key Data Information from Secondary Sources           109

Table 124. Key Data Information from Primary Sources               109

Table 125. Authors List of This Report             110

List of Figures

Figure 1. Product Picture of Enoxaparin API  1

Figure 2. Global Enoxaparin API Market Value by Anti-factor Xa Activity, (US$ Million) & (2024 VS 2031)       2

Figure 3. Global Enoxaparin API Market Share by Anti-factor Xa Activity: 2024 VS 2031        3

Figure 4. Enoxaparin Sodium Injection Preparation       4

Figure 5. Global Enoxaparin API Market Value by Application, (US$ Million) & (2024 VS 2031)       5

Figure 6. Global Enoxaparin API Market Share by Application: 2024 VS 2031        5

Figure 7. Global Enoxaparin API Production Value (US$ Million), 2020 VS 2025 VS 2031  7

Figure 8. Global Enoxaparin API Production Value (US$ Million) & (2020-2031)           8

Figure 9. Global Enoxaparin API Production Capacity (Kg) & (2020-2031)      8

Figure 10. Global Enoxaparin API Production (Kg) & (2020-2031)                 9

Figure 11. Global Enoxaparin API Average Price (USD/Kg) & (2020-2031)      10

Figure 12. Enoxaparin API Report Years Considered    12

Figure 13. Enoxaparin API Production Share by Manufacturers in 2024                 14

Figure 14. Enoxaparin API Production Value Share by Manufacturers in 2024        16

Figure 15. Enoxaparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024              18

Figure 16. The Global 5 and 10 Largest Players: Market Share by Enoxaparin API Revenue in 2024      22

Figure 17. Global Enoxaparin API Production Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million)                25

Figure 18. Global Enoxaparin API Production Value Market Share by Region: 2020 VS 2024 VS 2031          25

Figure 19. Global Enoxaparin API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)               28

Figure 20. Global Enoxaparin API Production Market Share by Region: 2020 VS 2024 VS 2031        28

Figure 21. North America Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031)         31

Figure 22. Europe Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031)   32

Figure 23. China Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031) 32

Figure 24. India Enoxaparin API Production Value (US$ Million) Growth Rate (2020-2031) 33

Figure 25. Global Enoxaparin API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)        35

Figure 26. Global Enoxaparin API Consumption Market Share by Region: 2020 VS 2024 VS 2031        35

Figure 27. North America Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)             37

Figure 28. North America Enoxaparin API Consumption Market Share by Country (2020-2031)           39

Figure 29. U.S. Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         39

Figure 30. Canada Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         40

Figure 31. Europe Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         40

Figure 32. Europe Enoxaparin API Consumption Market Share by Country (2020-2031)           42

Figure 33. Germany Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)             43

Figure 34. France Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         43

Figure 35. U.K. Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         44

Figure 36. Italy Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         44

Figure 37. Spain Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         45

Figure 38. Asia Pacific Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)             45

Figure 39. Asia Pacific Enoxaparin API Consumption Market Share by Region (2026-2031)             47

Figure 40. China Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         48

Figure 41. Japan Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         48

Figure 42. South Korea Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)             49

Figure 43. Southeast Asia Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)             49

Figure 44. India Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         50

Figure 45. Australia Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)             50

Figure 46. Latin America Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)             51

Figure 47. Latin America Enoxaparin API Consumption Market Share by Country (2020-2031)           52

Figure 48. Mexico Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         53

Figure 49. Brazil Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)         53

Figure 50. Middle East and Africa Enoxaparin API Consumption and Growth Rate (2020-2031) & (Kg)     54

Figure 51. Global Production Market Share of Enoxaparin API by Anti-factor Xa Activity (2020-2031)           56

Figure 52. Global Production Value Market Share of Enoxaparin API by Anti-factor Xa Activity (2020-2031)  58

Figure 53. Global Enoxaparin API Price (USD/Kg) by Anti-factor Xa Activity (2020-2031)            59

Figure 54. Global Production Market Share of Enoxaparin API by Application (2020-2031)     62

Figure 55. Global Production Value Market Share of Enoxaparin API by Application (2020-2031)     64

Figure 56. Global Enoxaparin API Price (USD/Kg) by Application (2020-2031)      65

Figure 57. Enoxaparin API Value Chain           92

Figure 58. Heparin Sodium Production Process             94

Figure 59. Enoxaparin API Production Process              95

Figure 60. Channels of Distribution (Direct Vs Distribution)      96

Figure 61. Bottom-up and Top-down Approaches for This Report                 107

Figure 62. Data Triangulation            108

QYResearchは広範な市場を対象にし、多様な市場調査レポートを出版している中国北京に本社をおく市場調査会社です。QYResearch出版の市場調査レポートに関するご質問やサンプルページのご依頼等はいつでもお気軽にお問合せください。

QYResearch 出版レポート一覧

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイル閲覧可のライセンスです。
    • 提供ファイルはPDFファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • マルチユーザライセンス
    • 同一企業内10名までレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
  • エンタープライズライセンス
    • 同一企業および関連会社内において人数無制限でレポートファイルの閲覧可のライセンスです。
    • 提供ファイルはPDFとExcelファイルです。
    • 納品ファイルは印刷可、コピー＆ペースト可。
• 納期
  • 既刊レポート：ご注文後3営業日以内
  • オンデマンドレポート：通常7営業日前後

• 納品形態
  • Eメール

注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでのご注文をお待ちしております。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。